Microsoft 's MSFT Azure AI services are gaining meaningful enterprise traction, and the momentum is increasingly shaping the investment case for the stock. In the second quarter of fiscal 2026, Azure ...
Stocks rose on Wednesday, building on the momentum seen late in the previous session, as the surge in oil prices pulled back following developments in the U.S.-Israeli war on Iran and fears about a ...
Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results